Pancreatic Cancer Detection Consortium (NCT06388967)

🧪 Interventions in This Study

• PANcreatic cancer Exosome Early detectiON (PANXEON) (DIAGNOSTIC_TEST)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (11 Sites)

• Translational Genomics Research Institute — Phoenix, Arizona
• Honorhealth — Scottsdale, Arizona
• City of Hope Medical Center — Monrovia, California
• Hoag Center — Newport Beach, California
• OSF HealthCare — Peoria, Illinois
• Ochsner Medical Center — Jefferson, Louisiana
• Atlantic Health System — Morristown, New Jersey
• Piedmont Medical Center — Rock Hill, South Carolina
• Medical College of Wisconsin — Milwaukee, Wisconsin
• Nagoya University — Nagoya,
• Asan Medical Center — Seoul,

📞 Contact the Study Coordinator

Phone: (626) 218-3452

Email: AJGOEL@COH.ORG

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Pancreatic Cancer

• A Study of the Life Changes Experienced by Patients With Pancreatic Cancer — New York, New York
• Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas Cancer — Baltimore, Maryland
• Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma — Hartford, Connecticut
• Pulse-low-dose Rate (PLDR) Radiation in Pancreatic Cancer — Philadelphia, Pennsylvania
• Use of High-dose Radiation Therapy Plus Chemotherapy to Improve the Likelihood of Surgical Treatment in Patients With Locally Advanced Pancreatic Cancer — Basking Ridge, New Jersey
• Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas — Baltimore, Maryland

Explore by condition: All Pancreatic Cancer clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.